"Burkitt Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
Descriptor ID |
D002051
|
MeSH Number(s) |
C02.256.466.313.165 C02.928.313.165 C04.557.386.480.150.165 C15.604.515.569.480.150.165 C20.683.515.761.480.150.165
|
Concept/Terms |
Burkitt Lymphoma- Burkitt Lymphoma
- Burkitt Leukemia
- Leukemia, Burkitt
- Leukemia, Lymphoblastic, Burkitt-Type
- Burkitt's Lymphoma
- Burkitts Lymphoma
- Lymphoma, Burkitt's
- Burkitt Cell Leukemia
- Cell Leukemia, Burkitt
- Leukemia, Burkitt Cell
- Burkitt's Tumor
- Burkitts Tumor
- Tumor, Burkitt's
- Burkitt Tumor
- Tumor, Burkitt
- Leukemia, Lymphocytic, L3
- Lymphocytic Leukemia, L3
- L3 Lymphocytic Leukemia
- L3 Lymphocytic Leukemias
- Leukemia, L3 Lymphocytic
- Leukemias, L3 Lymphocytic
- Lymphocytic Leukemias, L3
- Burkitt's Leukemia
- Burkitts Leukemia
- Leukemia, Burkitt's
- Lymphoma, Burkitt
|
Below are MeSH descriptors whose meaning is more general than "Burkitt Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Burkitt Lymphoma".
This graph shows the total number of publications written about "Burkitt Lymphoma" by people in this website by year, and whether "Burkitt Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 0 | 1 | 1 |
1996 | 2 | 2 | 4 |
1997 | 1 | 2 | 3 |
1998 | 4 | 1 | 5 |
1999 | 4 | 0 | 4 |
2000 | 2 | 1 | 3 |
2001 | 1 | 3 | 4 |
2002 | 3 | 4 | 7 |
2003 | 4 | 0 | 4 |
2004 | 3 | 2 | 5 |
2005 | 1 | 0 | 1 |
2006 | 5 | 2 | 7 |
2007 | 6 | 1 | 7 |
2008 | 1 | 1 | 2 |
2009 | 0 | 2 | 2 |
2010 | 2 | 1 | 3 |
2011 | 6 | 2 | 8 |
2012 | 2 | 2 | 4 |
2013 | 5 | 0 | 5 |
2014 | 2 | 0 | 2 |
2015 | 2 | 0 | 2 |
2016 | 4 | 2 | 6 |
2017 | 5 | 1 | 6 |
2019 | 4 | 1 | 5 |
2020 | 7 | 1 | 8 |
2021 | 5 | 1 | 6 |
2022 | 6 | 0 | 6 |
2023 | 5 | 0 | 5 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Burkitt Lymphoma" by people in Profiles.
-
Pediatric sporadic Burkitt lymphoma of the head and neck: A case series and analysis of national trends. Int J Pediatr Otorhinolaryngol. 2024 Nov; 186:112137.
-
HSR24-130: Real-World Outcomes in Patients With Burkitt Lymphoma in a Safety-Net Health System. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5).
-
Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Jul-Aug; 27(4):348-353.
-
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report. Leukemia. 2024 Apr; 38(4):720-728.
-
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Feb; 30(2):217-227.
-
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL. Blood Adv. 2023 10 24; 7(20):6320-6324.
-
From the archives of MD Anderson Cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression. Ann Diagn Pathol. 2023 Oct; 66:152182.
-
Non-viral TRAC-knocked-in CD19KICAR-T and gp350KICAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency. Front Immunol. 2023; 14:1086433.
-
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. Am J Hematol. 2023 06; 98(6):E142-E144.
-
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023 02 23; 141(8):904-916.